Company / R&D per Share
Anixa Biosciences Inc R&D per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.21
FY2024
5-year range
$0.21 / $0.36
FY2020-FY2024
Trend
-5.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 8 years, ranging from $0.08 in FY2016 to $0.36 in FY2019.
Based on SEC 10-K filings.
0.21 in FY2024 with a 5-year CAGR of -10.6%.
Remained stable around $0.21 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -10.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, r&d per share decreased 5.3% year-over-year.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.21 | -5.3% |
| FY2023 | $0.22 | +5.3% |
| FY2022 | $0.21 | -23.5% |
| FY2020 | $0.27 | -25.3% |
| FY2019 | $0.36 | +274.5% |
| FY2018 | $0.10 | -45.9% |
| FY2017 | $0.18 | +118.1% |
| FY2016 | $0.08 | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026